1,2 Ro 48-8071 是一种 OSC 抑制剂,具有类似于 3-羟基-3-甲基戊二酰辅酶 A(HMG-CoA)抑制剂辛伐他汀的降低低密度脂蛋白(LDL)胆固醇活性。3 Ro 48-8071 能降低仓鼠体内约 40% 的低密度脂蛋白胆固醇,剂量为 150 µg/kg,但不影响高密度脂蛋白水平,也没有肝脏毒性迹象。3 Ro 48-8071 能提高原代大鼠和小鼠肝细胞培养物中细胞色素 P3A mRNA 和蛋白质的水平,30 µM 时作用最大。
Ro 48-8071 (CAS 161582-11-2) 参考文献
1 Vance, D.E. Cholesterol and related derivatives. 2nd ed., 725-748 (1988). 2 Thoma, R., Schulz-Gasch, T., D'Arcy, B., et al. Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase. Nature 432 118-122 (2004). 3 Morand, O.H., Aebi, J.D., Dehmlow, H., et al. Ro 48-8071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: Comparison to simvastatin. J Lipid Res 38 373-390 (1997). 4 Shenoy, S.D., Spencer, T.A., Mercer-Haines, N.A., et al. Induction of CYP3A by 2,3-Oxidosqualene:Lanosterol cyclase inhibitors is mediated by an endogenouse squalene metabolite in primary cultured rat hepatocytes. Mol Pharmacol 65 1302-1312 (2004).